May 15
WLSS · Welsis Corp.
$0.60
At close · Jul 17
Return incl. dividend (before tax)
Going-concern doubt
— flagged Feb 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the financial statements, the Company had an accumulated deficit of $236,146 at December 31, 2025 and negative operating cash flow of $10,525 for the three months ended December 31, 2025. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Feb 17, 2026
Market Cap
$1.65M
Shares
2.75M
Volume · Jul 17
200
Avg daily vol (2 sessions)
300
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.60
Open$0.60
Day$0.60–0.60
52W close$0.40–4.60
Avg vol 30d1K
Short int36 · 0.0% of shares · 1.0d
Short vol57%
DataMay 2024–Jul 2026
Filing10-Q · Feb 17
Latest documents
2026
Feb 17
Quarterly report
10-Q
FY2026 Q1, ended Dec 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $0
Net loss $10.02K
Diluted EPS $0.00
Jan 13
Annual report
10-K
FY2025, ended Sep 30
Annual report for FY2025
AI summary on its way
Revenue $0
Net loss $60.69K
Diluted EPS -$0.02
2025
Dec 30
Late filing notice
NT 10-K
Late filing notice
Aug 12
Quarterly report
10-Q
FY2025 Q3, ended Jun 30
Quarterly report for FY2025 Q3
Revenue $0
Net loss $8718
Diluted EPS $0.00
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$46,454
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$118,417
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-80.0%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−78%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
5%
near low
Momentum
relative strength
1-month return
−80%
trailing
6-month return
−82%
trailing
YTD return
−75%
this year
Relative strength
−90%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of shares out · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−100%
Y/Y
Balance sheet
$107.9K
net debt
Quant / Vol
risk profile
Volatility
1060%
annualized · 1-yr
Max drawdown
−92%
past year
ATR
265.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−78%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of shares out · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $1 · 5%
Range high $5
vs 50-day avg -78%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WLSS
this stock
Welsis Corp.
|
$1.65M | — | -100.0% | — | 0.0% |
|
VEEV
Veeva Systems Inc
|
$48.96B | +35.5% | +28.1% | 49.5 | 2.4% |
|
PMDIY
Pro Medicus Ltd.
|
$14.81B | -14.6% | — | — | 0.1% |
|
BTSG
BrightSpring Health Services, Inc.
|
$14.22B | +90.8% | +28.2% | 38.8 | 0.0% |
|
TEM
Tempus AI, Inc.
|
$13.84B | +28.5% | +83.4% | — | 13.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WLSS | -67.9% | -79.8% | -82.5% | -75.9% | -75.0% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -66.4% | -80.1% | -90.3% | -75.4% | -84.0% |
Key facts
CIK
1887912